Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to $8143.0.

  • Cannabis Bioscience International Holdings' Cost of Revenue fell 261.9% to $8143.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $39887.0, marking a year-over-year decrease of 1163.91%. This contributed to the annual value of $40106.0 for FY2025, which is 1204.63% down from last year.
  • Per Cannabis Bioscience International Holdings' latest filing, its Cost of Revenue stood at $8143.0 for Q3 2025, which was down 261.9% from $4545.0 recorded in Q2 2025.
  • In the past 5 years, Cannabis Bioscience International Holdings' Cost of Revenue registered a high of $24120.0 during Q1 2023, and its lowest value of $4545.0 during Q2 2025.
  • Its 4-year average for Cost of Revenue is $11755.4, with a median of $9349.0 in 2023.
  • Per our database at Business Quant, Cannabis Bioscience International Holdings' Cost of Revenue soared by 11286.32% in 2023 and then crashed by 5398.87% in 2025.
  • Over the past 4 years, Cannabis Bioscience International Holdings' Cost of Revenue (Quarter) stood at $7090.0 in 2022, then soared by 112.86% to $15092.0 in 2023, then plummeted by 48.3% to $7803.0 in 2024, then increased by 4.36% to $8143.0 in 2025.
  • Its last three reported values are $8143.0 in Q3 2025, $4545.0 for Q2 2025, and $19396.0 during Q1 2025.